China to Remove Paxlovid From Insurance Drug List

NTD Newsroom
By NTD Newsroom
January 12, 2023China in Focus
share

With demand for antiviral drugs skyrocketing amid the COVID-19 outbreak in China, the CCP says it will remove a certain medication from its health insurance drug list in April.

The targeted drug is called Paxlovid— an antiviral made by U.S. drug maker Pfizer.

Chinese authorities attributed the removal to a high price for the COVID-19 drug quoted by the U-S firm.

China in Focus Weekly Newsletter
Find out what's really going on in China
By registering for the newsletter, you agree to the Privacy Policy.